Lenalidomide (LEN) Combined To Intensive Chemotherapy (IC) In AML and Higher Risk MDS With Del 5q. Results Of a Phase I/II Study Of The Groupe Francophone …
T Prebet, A Stamatoullas, C Recher, R Guieze… – Blood, 2013
… France,; 5 Hematologie, CHU Estaing, Clermont-Ferrand, France,; 6 Hematology,
Hôpital Saint-Louis, AP–HP, Paris, France,; 7 Service d’Hématologie et de Thérapie
Cellulaire, University Hospital of Bordeaux, Pessac, France,; …
Recommandations concernant l’incontinence urinaire de la personne âgée: construction et validation de l’algorithme décisionnel GRAPPPA
G Amarenco, X Gamé, AC Petit, B Fatton, C Jeandel… – Progrès en Urologie, 2014
… a Service de neuro-urologie, hôpital Tenon, AP–HP, GRC01 UPMC GREEN, 4, rue
de la Chine, 75020 Paris, France; b Département d’urologie, transplantation rénale
et andrologie, CHU Rangueil, 31059 Toulouse, France; c …
Administration orale de médicaments au nourrisson: réalisation d’une analyse préliminaire des risques dans un service d’hospitalisation pédiatrique
M Pourrat, C Delescluse, S Merlin, S Sauvion, S Carret… – Annales Pharmaceutiques …, 2013
… Toutes ces solutions s’inscrivent en ligne directe avec les recommandations établies par
l’inspection générale des affaires sociales (IGAS) à propos du circuit du médicament à
l’Assistance Publique–Hôpitaux de Paris (AP–HP) [20]. Gestion des risques. …
The Revised IPSS (IPSS-R) Predicts Response To Erythropoietic Stimulating agents (ESA) In Pts With Classical IPSS Low Or Intermediate-1 (int 1)-MDS: A Joint …
V Santini, J Schemenau, A Levis, E Balleari, R Sapena… – Blood, 2013
… Chieri, Italy,; 14 Università di Torino, Torino, Italy,; 15 Hematology, Hôpital Saint-Louis,
AP–HP, Paris, France,; 16 Hématologie clinique, Hôpital Saint Vincent de Paul
Université Catholique de Lille, Lille, France,; 17 Hematology …
Characterization of four novel molecular changes in the promoter region of the factor VIII gene
C Nougier, O Roualdes, M Fretigny, R d’Oiron, C Costa… – Haemophilia, 2013
… Lyon, France. 3 Centre de Traitement pour Hémophiles, AP–HP Hôpital Bicêtre,
Université Paris XI, le Kremlin-Bicêtre, France. 4 Département de Génétique, CHU
Henri Mondor-AP–HP, Créteil, France. * Correspondence: Christophe …
Trajectories of the Framingham general cardiovascular risk profile in midlife and poor motor function later in life: The Whitehall II study
A Elbaz, MJ Shipley, H Nabi, EJ Brunner, M Kivimaki… – International Journal of …, 2013
… d Centre de Gérontologie, Hôpital Ste Périne, AP–HP, France. Received 12 May
2013 Revised 11 December 2013 Accepted 20 December 2013 Available online
29 December 2013. Abstract. Background. Vascular risk factors …
Virtual Continuous CWmin Control Scheme of WLAN
Y SANGENYA, F INOUE, M MORIKURA… – IEICE TRANSACTIONS on …, 2014
… x(t) = min Φ (bΦ(t)), (5) where bΦ(t) is the backoff counter value of WSΦ at time t. The WSΦ is
considered as AP HP, AP LP, or STA in the case of the proposed VCCC scheme. As described
in Fig. 3, AP HP and AP LP represent as the AP with the HP and LP states, respectively. …
Managing Fever in Children: A National Survey of Parents’ Knowledge and Practices in France
N Bertille, E Fournier-Charrière, G Pons, M Chalumeau – PLOS ONE, 2013
… Nathalie Bertille, Affiliations: Inserm U953 Epidemiological Research Unit on Perinatal Health
and Women’s and Children’s Health, Paris, France, Paris-Descartes University, Paris, France,
Department of Paediatrics, Hôpital Necker-Enfants Malades, AP–HP, Paris, France. …
Fetal intracerebral hemorrhage and cataract: think COL4A1
E Colin, L Sentilhes, A Sarfati, M Mine, A Guichet… – Journal of Perinatology, 2014
… 3 Department of Neurovascular Genetics, AP–HP, Hospital Group Saint-Louis
Lariboisiere-Fernand-Widal, Paris, France; 4 Department of Radiology, Angers
University Hospital, Angers, France. Correspondence: Professor D …
A Phase II Study Of The Efficacy and Safety Of An Intensified Schedule Of Azacitidine (AZA) In Intermediate-2 and High Risk MDS Patients
A Guerci-Bresler, PC Makhoul, L Legros, J Delaunay… – Blood, 2013
… 8 Groupe Francophone des Myelodysplasies (GFM), bobigny, France,; 9 Hôpital
Saint-Louis, AP–HP, Université Paris 7, Paris, France,; 10 Hematology Department,
Avicenne Hospital APHP University Paris XIII, Bobigny, France. Abstract. …
The Addition Of Gemtuzumab Ozogamicin (GO) To Induction Chemotherapy Reduces Relapse and Improves Survival In Patients Without Adverse Risk Karyotype: …
S Petersdorf, EH Estey, M Othus, FR Appelbaum… – Blood, 2013
… Seattle, WA, USA,; 6 Hematology, Hôpital de Versailles, Le Chesnay, France,; 7
Hematology Department, Hopital Saint Louis AP–HP, Paris, France,; 8 Hôpital
Saint-Louis, AP–HP, Université Paris 7, Paris, France,; 9 Hematology …
French guidelines for enhanced recovery after elective colorectal surgery
P Alfonsi, K Slim, M Chauvin, P Mariani, JL Faucheron… – Journal of Visceral Surgery, 2013
… Organizing committee. SFAR. Pascal Alfonsi, Service Anesthésie-réanimation, Hôpital
Cochin, AP–HP, Paris. Marcel Chauvin, Service Anesthésie-réanimation, Hôpital
Ambroise-Paré, AP–HP, Boulogne-Billancourt. Dominique …
Accurate Classification Of GCB/ABC and MYC/BCL2 Diffuse Large B-Cell Lymphoma With a 14 Genes Expression Signature and a Simple and Robust RT-MLPA …
S Mareschal, C Bagacean, V Rainville, K Leroy, JP Jais… – Blood, 2013
… Rouen, France,; 2 Pathology, Université Paris Est Créteil, AP–HP, 94010 Créteil
Cedex, France,; 3 INSERM UMR872, AP–HP, Hôpital Necker, Service de
Biostatistique ; Université Paris Descartes, Paris, France,; 4 Plateforme …
A Genome-Wide Association Study (GWAS) Of Event-Free Survival In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Rituximab and Anthracycline-Based …
SL Slager, F Jardin, AS Veron, A Novak, MJ Maurer… – Blood, 2013
… Clinic, Rochester, MN, USA,; 15 Department of Health Sciences Research, Mayo
Clinic, Jacksonville, FL, USA,; 16 Pathology, Universite Paris Descartes, AP–HP,
Hopital Hotel-Dieu, Paris, France,; 17 Department of Medicine …
Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response
F Bani-Sadr, D Fromentin, C Goujard, M Hessamfar… – Journal of Infection, 2013
… Médecine de Reims, Reims; d Service de Maladies Infectieuses et Tropicales, APHP,
Le Kremlin Bicetre; e Groupe Hospitalier Universitaire Paris-Sud, AP–HP, INSERM
U1018, Le Kremlin Bicêtre; f CHU de Bordeaux, Services …
Ninety-Day Morbidity in Patients Undergoing Primary TKA with Discontinuation of Warfarin and Bridging with LMWH
E Gibon, N Barut, P Anract, JP Courpied… – The Journal of Arthroplasty, 2013
… Jean-Pierre Courpied, MD,; Moussa Hamadouche, MD, PhD. Department of
Reconstructive and Orthopaedic Surgery, Clinical Orthopaedic Research Centre,
Université Paris Descartes, Hôpital Cochin (AP–HP), Paris, France. …
Susceptibility Loci for Pigmentation and Melanoma in Relation to Parkinson’s disease
J Dong, J Gao, M Nalls, X Gao, X Huang, J Han… – Neurobiology of Aging, 2013
… Branch, National Institute of Environmental Health Sciences), Frank Durif (Service de Neurologie,
Hôpital Gabriel Montpied, Clermont-Ferrand, France), Alexandra Dürr (INSERM, UMR_S975;
Université Pierre et Marie Curie-Paris; CNRS; and AP–HP, Pitié-Salpêtrière Hospital …
